SCHEMBL10122293

SCHEMBL10122293

CCN(CC)CCCS(=O)(=O)N[C@H](Cc1ccccc1)c1nc(CNC(=O)N(CC)CC)n(C)n1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 1/20 0.41
LMNA P02545 1/20 0.38
GAA P10253 1/20 0.35
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
CYP2D6 P10635 1/20 0.32
DUT P33316 1/20 0.32
ALDH1A1 P00352 1/20 0.32
CYP3A4 P08684 1/20 0.32
HPGD P15428 1/20 0.32
HDAC1 Q13547 2/20 0.32
HDAC6 Q9UBN7 1/20 0.32
CTSL P07711 2/20 0.32
KDM4E B2RXH2 1/20 0.32
S1PR1 P21453 2/20 0.31
GPR55 Q9Y2T6 1/20 0.31
CCR5 P51681 1/20 0.31
HDAC8 Q9BY41 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1709734 0.92 GHSR (0.49) GHSRLMNAGAAMEN1KMT2A
SCHEMBL10122289 0.88 HDAC1 (0.41) GHSRLMNACYP3A4HDAC1HDAC6
SCHEMBL10122142 0.88 CCR5 (0.41) GHSRLMNAKMT2ACCR5
SCHEMBL1709610 0.87 GHSR (0.38) GHSRLMNAGAAMEN1KMT2A
SCHEMBL1709729 0.85 GHSR (0.48) GHSRLMNAGAAMEN1KMT2A
SCHEMBL10122136 0.84 GHSR (0.39) GHSRLMNAGAACYP2D6DUT
SCHEMBL10121697 0.84 GHSR (0.47) GHSRLMNAGAACYP2D6DUT
SCHEMBL1709723 0.84 GHSR (0.44) GHSRLMNAMEN1KMT2ADUT
SCHEMBL1709725 0.83 HDAC1 (0.41) GHSRLMNACYP3A4HDAC1HDAC6
SCHEMBL10121719 0.82 GHSR (0.48) GHSRLMNAGAAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120088747-A1 SULFONAMIDE CONTAINING COMPOUNDS AND USES THEREOF ELIXIR PHARMACEUTICALS, INC. 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088747-A1 SULFONAMIDE CONTAINING COMPOUNDS AND USES THEREOF GHSR, GHRHR, STS GHSR 1/4885LMNA 3245/4885GAA 55/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.